STOCK TITAN
  1. Home
  2. Sec-filings
  3. IQV
  4. [8-K] IQVIA HOLDINGS INC. Reports Material Event

€950M IQVIA (NYSE: IQV) senior notes due 2033 for refinancing debt

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

IQVIA Holdings Inc. announced that its subsidiary, IQVIA Inc., has priced an offering of €950,000,000 in senior notes due 2033. The notes will bear interest at 4.625% per annum, paid semi-annually on June 15 and December 15, starting December 15, 2026, and will mature on June 15, 2033 unless earlier repurchased or redeemed. IQVIA plans to use the proceeds to refinance certain existing indebtedness and to pay fees and expenses related to the transaction. The issuance is expected to close on or about June 11, 2026, subject to customary closing conditions, and the notes are being sold in a private offering to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S.

Positive

  • None.

Negative

  • None.

Insights

IQVIA adds €950M of 2033 debt mainly to refinance existing obligations.

IQVIA, via its subsidiary IQVIA Inc., is issuing €950,000,000 of senior notes due 2033 at a 4.625% coupon. The company states that proceeds will refinance certain existing indebtedness and cover related fees and expenses, so this is primarily a maturity and cost-management move rather than incremental growth capital.

The notes are offered privately to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S, which avoids immediate public registration requirements. Actual impact on leverage and interest expense will depend on which debts are refinanced and their existing terms, details that are not specified here.

The transaction’s completion remains subject to customary closing conditions, with settlement expected around June 11, 2026. Subsequent disclosures may clarify the specific facilities or notes being refinanced and any resulting changes to the company’s average borrowing cost and debt maturity profile.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Senior notes size €950,000,000 aggregate principal Priced offering by IQVIA Inc.
Coupon rate 4.625% per annum Interest on senior notes
Maturity date June 15, 2033 Senior notes due date
Interest payment dates June 15 and December 15 Semi-annual payments beginning December 15, 2026
Expected issuance date On or about June 11, 2026 Closing of notes offering
Employee count Approximately 93,000 employees Global workforce in over 100 countries
senior notes financial
"priced an offering of €950,000,000 in aggregate principal amount of senior notes due 2033"
Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.
aggregate principal amount financial
"priced an offering of €950,000,000 in aggregate principal amount of senior notes due 2033"
The aggregate principal amount is the total amount of money borrowed through a bond or loan that the borrower promises to repay. It’s like the original price tag on a loan or bond, showing how much money is involved in the deal. This number matters because it indicates the size of the debt and helps investors understand the scale of the borrowing.
Rule 144A regulatory
"offered only to persons reasonably believed to be qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act"
Rule 144A is a regulation that makes it easier for companies to sell private bonds to large investors without going through all the usual rules that apply to public sales. It matters because it helps companies raise money more quickly and privately, often attracting big investors looking for special deals.
Regulation S regulatory
"outside the United States only to non-U.S. investors pursuant to Regulation S under the Securities Act"
Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.
forward-looking statements regulatory
"Certain statements in this press release are forward-looking statements."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

What type of debt is IQVIA (IQV) issuing in this 8-K announcement?
IQVIA’s subsidiary is issuing €950,000,000 of senior notes due 2033. These notes carry a fixed 4.625% annual interest rate, pay interest semi-annually, and rank as senior obligations of the issuer within its capital structure.

What is the interest rate and maturity of IQVIA’s new senior notes?
The new senior notes bear interest at 4.625% per annum and mature on June 15, 2033. Interest will be paid semi-annually in arrears on June 15 and December 15, beginning December 15, 2026, unless the notes are earlier repurchased or redeemed.

How will IQVIA (IQV) use the proceeds from the €950 million notes offering?
IQVIA plans to use the notes proceeds to refinance certain existing indebtedness and pay fees and expenses related to the offering. This indicates the transaction primarily reshapes the company’s debt profile rather than funding new operating or acquisition initiatives.

When is the issuance of IQVIA’s 2033 senior notes expected to close?
The issuance of the senior notes is expected to occur on or about June 11, 2026. Closing is subject to the satisfaction of customary conditions typically associated with institutional debt offerings, such as documentation and regulatory and market requirements.

Who can purchase IQVIA’s new senior notes under this offering?
The notes are being offered only to qualified institutional buyers in the United States under Rule 144A and to non-U.S. investors under Regulation S. Any sale will be made solely through a private offering memorandum, not a public prospectus.

Are IQVIA’s new senior notes registered under the Securities Act of 1933?
The notes have not been registered under the Securities Act of 1933 or any state securities laws. They cannot be offered or sold in the United States without registration or a valid exemption, reflecting the private placement structure of this financing.
false 0001478242 0001478242 2026-06-04 2026-06-04
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 4, 2026

 

 

IQVIA HOLDINGS INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35907   27-1341991

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

2400 Ellis Road

Durham, North Carolina

   27703
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (919) 998-2000

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

  

Trading
Symbol

  

Name of Each Exchange

on which Registered

Common Stock, par value $0.01
per share		   “IQV”   New York Stock Exchange

 

 
 

Item 8.01

Other Events

On June 4, 2026, IQVIA Holdings Inc. issued a press release announcing that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €950,000,000 in aggregate principal amount of senior notes due 2033 bearing interest at a rate of 4.625% per annum (the “Notes”). The Issuer entered into a purchase agreement with the representative of the purchasers named therein, relating to the issuance and sale of the Notes. The consummation of the Notes offering, which is expected to occur on or about June 11, 2026, is subject to the satisfaction of customary closing conditions. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01

Financial Statements and Exhibits

(d) Exhibits.

 

Exhibit
No.		    Description
99.1    Pricing press release dated June 4, 2026
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 4, 2026

 

IQVIA HOLDINGS INC.
By:  

/s/ Eric M. Sherbet

  Eric M. Sherbet
  Executive Vice President, General Counsel, and Secretary

Exhibit 99.1

IQVIA Announces Pricing of Senior Notes

June 4, 2026

RESEARCH TRIANGLE PARK, N.C. – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €950,000,000 in aggregate principal amount of senior notes due 2033 (the “Notes”). The proceeds from the Notes offering will be used to refinance certain of the Issuer’s existing indebtedness and to pay fees and expenses related to the Notes offering.

The Notes will bear interest at a rate of 4.625% per annum and will pay interest semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2026. The Notes will mature on June 15, 2033, unless earlier repurchased or redeemed in accordance with their terms. The issuance of the Notes is expected to occur on or about June 11, 2026, subject to the satisfaction of customary closing conditions.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall there be any offer, solicitation or sale of the Notes in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful. The Notes to be offered have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act. The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act and outside the United States only to non-U.S. investors pursuant to Regulation S under the Securities Act. Any offer of the Notes will be made only by means of a private offering memorandum.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 93,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.

Forward Looking Statements

Certain statements in this press release are forward-looking statements. These statements involve a number of risks, uncertainties and other factors, including the failure to consummate the Notes offering, and potential changes in market conditions that could cause actual results to differ materially.

IQVIAFIN

Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)

+1.973-541-3558

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents

Press Releases

Other Documents